Amexdrug Corporation, through its subsidiaries, engages in the research, development, manufacturing, and distribution of pharmaceutical drugs in the United States. The company operates in two segments, Distribution, and Health and Beauty Products. It offers brand and generic pharmaceuticals, prescription and over-the-counter drugs, non-drug products, health and beauty products, nutritional supplements, as well as pharmacy and laboratory supplies under the Sponix brand name. The company is also involved in private manufacturing and labeling activities. It sells its products through traditional wholesale distribution lines, e-commerce venues, and owned website to independent pharmacies, secondarily to small-sized pharmacy chains, and alternative care facilities, as well as wholesalers and retailers. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000. Amexdrug Corporation was incorporated in 1963 and is based in Commerce, California.
0 transactions — 0 buys and 0 sales reported by Amexdrug Corporation executives.
0 institutional funds report a position on AXRX in their latest SEC quarterly filing.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of AXRX on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year